Market Place
Sourcing Support
All News #Library
Rubin Research’s Generics Ibuprofen Receives Approval in US
05 Mar 2026 //
FDA
Rubin Research’s Generics Cetirizine HCl Receives Approval in US
25 Feb 2026 //
FDA
Rubin’s Generics Rimegepant Receives Tentative Approval in US
14 Jan 2026 //
FDA
Rubicon’s Generics Chlorpromazine HCl Receives Approval in US
10 Oct 2025 //
FDA
Rubicon’s Receives First Generic Approval for Ivermectin in US
22 Jan 2025 //
FDA
Rubicon`s Generics Ipratropium Br Receives Approval in US
14 Jan 2025 //
FDA
Rubicon`s Generics Bumetanide Receives Approval in US
27 Dec 2024 //
FDA
Rubicon`s Generic Tranexamic Acid Receives Approval in US
11 Jun 2024 //
FDA
Rubicon`s Generic Carbidopa; Levodopa Receives Approval in US
04 Jun 2024 //
FDA
Enforcement Report - Week of May 15, 2024
15 May 2024 //
FDA
Rubicon`s Generic Nortriptyline Hydrochloride Receives Approval in the U.S.
15 Aug 2023 //
FDA
Rubicon`s Generic Lithium Citrate Receives Approval in the U.S.
14 Aug 2023 //
FDA
Rubicon`s Generic Potassium Chloride Receives Approval in the U.S.
16 Jun 2023 //
FDA
Rubicon`s Generic Diclofenac Sodium Receives Receives Approval in the U.S.
11 May 2023 //
FDA
Rubicon Research Generic Amitriptyline HCL Receives Approval in the U.S
01 May 2023 //
FDA
Rubicon`s Generic Cevimeline Hydrochloride Receives Approval in the U.S.
06 Apr 2023 //
FDA
Rubicon`s Generic Gabapentin Receives Approval in the U.S.
18 Jan 2023 //
FDA
Rubicon`s Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
14 Dec 2022 //
FDA
Rubicon`s Generic Aripiprazole Receives Approval in the U.S.
27 Oct 2022 //
FDA
Rubicon`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
21 Sep 2022 //
FDA
Rubicon`s Generic Oxcarbazepine Receives Approval in the U.S.
30 Aug 2022 //
FDA
Rubicon`s Generic Acyclovir Receives Approval in the U.S.
18 Aug 2022 //
FDA
Rubicon Generic Potassium Chloride Receives Approval in the U.S.
25 Jul 2022 //
FDA
Rubicon Research `s Isosorbide Dinitrate Receives Approval in US
08 Jul 2022 //
FDA
Rubicon Research ’s Generics Potassium Chloride Receives Approvals In US
24 Mar 2022 //
FDA
Rubicon`s Generic Pregabalin Receives Approval in the U.S.
22 Mar 2022 //
FDA
Rubicon`s Generic Potassium Chloride Receives Approval in the U.S.
13 Jan 2022 //
FDA
Rubicon`s Generic Metolazone Receives Approval In the US
20 Aug 2021 //
FDA
Rubicon`s Generic Labetalol HCl Receives Approval In the US
20 Aug 2021 //
FDA
Rubicon`s Generic Acetazolamide Receives Approval In the US
19 Aug 2021 //
FDA
Rubicon`s Generic Nitroglycerin Receives Tentative Approval In US
06 May 2021 //
FDA
Rubicon`s Generic Loratadine Receives Approval In US
15 Sep 2020 //
FDA
Rubicon`s Generic Amantadine hydrochloride Receives Approval In Us
26 May 2020 //
FDA
Rubicon`s Generic Midodrine hydrochloride Receives Approval In Us
22 Aug 2019 //
FDA
RUBICON`s generic TRAMADOL HYDROCHLORIDE Receives Approval in US
28 Jun 2019 //
FDA
Rubicon Res’s Generic Sildenafil Citrate Receives Approval In US
13 Jun 2018 //
FDA
Rubicon’s Generic Baclofen Receives Approval In US
29 Nov 2017 //
FDA
Rubicon Res Generic Cyclobenzaprine Hydrochloride Receives Approval In US
03 Jun 2017 //
FDA
Rubicon`s Generic Sildenafil Citrate Approved in US
20 Jun 2016 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.